Ceribell (CBLL) Net Income Growth (1y) (2024 - 2026)
Ceribell (CBLL) Net Income Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | 125.69% |
| 10 | Ceribell | 671.91 Mn | 530.73 Mn | 23.12 Mn | -54.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54.47% |
| Dec 31, 2025 | -7.56% |
| Sep 30, 2025 | -29.26% |
| Jun 30, 2025 | -52.59% |
| Mar 31, 2025 | -49.95% |
| Dec 31, 2024 | -51.99% |
| Sep 30, 2024 | -47.68% |